世界の多発梗塞性認知症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multi-Infarct Dementia Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3949
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多発梗塞性認知症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬理学的治療、非薬理学的治療）、用途別市場規模（学術、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多発梗塞性認知症の市場動向
・企業の競争状況、市場シェア
・多発梗塞性認知症の種類別市場規模（薬理学的治療、非薬理学的治療）
・多発梗塞性認知症の用途別市場規模（学術、病院、その他）
・多発梗塞性認知症の北米市場規模2016-2027（アメリカ、カナダ）
・多発梗塞性認知症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発梗塞性認知症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発梗塞性認知症の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発梗塞性認知症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Forest Laboratories、Janssen Pharmaceuticals、Novartis Pharmaceutical、Pfizer、Eisai、Ortho-McNeil Pharmaceutical、Takeda、Jubilant Cadista Pharmaceuticals、Takeda Pharmaceutical）
・結論

Multi-cerebral infarction dementia is a series of small strokes that cause disruption of blood flow to the brain. It is the highest incidence among people over 65 years of age.
The increase in the global elderly population has also contributed to the development of the global market for multi-infarct dementia.

Market Analysis and Insights: Global Multi-Infarct Dementia Market
The global Multi-Infarct Dementia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multi-Infarct Dementia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multi-Infarct Dementia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multi-Infarct Dementia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multi-Infarct Dementia market.

Global Multi-Infarct Dementia Scope and Market Size
Multi-Infarct Dementia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multi-Infarct Dementia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pharmacological Treatment
Non Pharmacological Treatment

Segment by Application
Academic
Hospitals
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Forest Laboratories
Janssen Pharmaceuticals
Novartis Pharmaceutical
Pfizer
Eisai
Ortho-McNeil Pharmaceutical
Takeda
Jubilant Cadista Pharmaceuticals
Takeda Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi-Infarct Dementia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacological Treatment
1.2.3 Non Pharmacological Treatment
1.3 Market by Application
1.3.1 Global Multi-Infarct Dementia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic
1.3.3 Hospitals
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multi-Infarct Dementia Market Perspective (2016-2027)
2.2 Multi-Infarct Dementia Growth Trends by Regions
2.2.1 Multi-Infarct Dementia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multi-Infarct Dementia Historic Market Share by Regions (2016-2021)
2.2.3 Multi-Infarct Dementia Forecasted Market Size by Regions (2022-2027)
2.3 Multi-Infarct Dementia Industry Dynamic
2.3.1 Multi-Infarct Dementia Market Trends
2.3.2 Multi-Infarct Dementia Market Drivers
2.3.3 Multi-Infarct Dementia Market Challenges
2.3.4 Multi-Infarct Dementia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multi-Infarct Dementia Players by Revenue
3.1.1 Global Top Multi-Infarct Dementia Players by Revenue (2016-2021)
3.1.2 Global Multi-Infarct Dementia Revenue Market Share by Players (2016-2021)
3.2 Global Multi-Infarct Dementia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multi-Infarct Dementia Revenue
3.4 Global Multi-Infarct Dementia Market Concentration Ratio
3.4.1 Global Multi-Infarct Dementia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-Infarct Dementia Revenue in 2020
3.5 Multi-Infarct Dementia Key Players Head office and Area Served
3.6 Key Players Multi-Infarct Dementia Product Solution and Service
3.7 Date of Enter into Multi-Infarct Dementia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multi-Infarct Dementia Breakdown Data by Type
4.1 Global Multi-Infarct Dementia Historic Market Size by Type (2016-2021)
4.2 Global Multi-Infarct Dementia Forecasted Market Size by Type (2022-2027)

5 Multi-Infarct Dementia Breakdown Data by Application
5.1 Global Multi-Infarct Dementia Historic Market Size by Application (2016-2021)
5.2 Global Multi-Infarct Dementia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multi-Infarct Dementia Market Size (2016-2027)
6.2 North America Multi-Infarct Dementia Market Size by Type
6.2.1 North America Multi-Infarct Dementia Market Size by Type (2016-2021)
6.2.2 North America Multi-Infarct Dementia Market Size by Type (2022-2027)
6.2.3 North America Multi-Infarct Dementia Market Size by Type (2016-2027)
6.3 North America Multi-Infarct Dementia Market Size by Application
6.3.1 North America Multi-Infarct Dementia Market Size by Application (2016-2021)
6.3.2 North America Multi-Infarct Dementia Market Size by Application (2022-2027)
6.3.3 North America Multi-Infarct Dementia Market Size by Application (2016-2027)
6.4 North America Multi-Infarct Dementia Market Size by Country
6.4.1 North America Multi-Infarct Dementia Market Size by Country (2016-2021)
6.4.2 North America Multi-Infarct Dementia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Multi-Infarct Dementia Market Size (2016-2027)
7.2 Europe Multi-Infarct Dementia Market Size by Type
7.2.1 Europe Multi-Infarct Dementia Market Size by Type (2016-2021)
7.2.2 Europe Multi-Infarct Dementia Market Size by Type (2022-2027)
7.2.3 Europe Multi-Infarct Dementia Market Size by Type (2016-2027)
7.3 Europe Multi-Infarct Dementia Market Size by Application
7.3.1 Europe Multi-Infarct Dementia Market Size by Application (2016-2021)
7.3.2 Europe Multi-Infarct Dementia Market Size by Application (2022-2027)
7.3.3 Europe Multi-Infarct Dementia Market Size by Application (2016-2027)
7.4 Europe Multi-Infarct Dementia Market Size by Country
7.4.1 Europe Multi-Infarct Dementia Market Size by Country (2016-2021)
7.4.2 Europe Multi-Infarct Dementia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multi-Infarct Dementia Market Size (2016-2027)
8.2 Asia-Pacific Multi-Infarct Dementia Market Size by Type
8.2.1 Asia-Pacific Multi-Infarct Dementia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multi-Infarct Dementia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multi-Infarct Dementia Market Size by Type (2016-2027)
8.3 Asia-Pacific Multi-Infarct Dementia Market Size by Application
8.3.1 Asia-Pacific Multi-Infarct Dementia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multi-Infarct Dementia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multi-Infarct Dementia Market Size by Application (2016-2027)
8.4 Asia-Pacific Multi-Infarct Dementia Market Size by Region
8.4.1 Asia-Pacific Multi-Infarct Dementia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multi-Infarct Dementia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multi-Infarct Dementia Market Size (2016-2027)
9.2 Latin America Multi-Infarct Dementia Market Size by Type
9.2.1 Latin America Multi-Infarct Dementia Market Size by Type (2016-2021)
9.2.2 Latin America Multi-Infarct Dementia Market Size by Type (2022-2027)
9.2.3 Latin America Multi-Infarct Dementia Market Size by Type (2016-2027)
9.3 Latin America Multi-Infarct Dementia Market Size by Application
9.3.1 Latin America Multi-Infarct Dementia Market Size by Application (2016-2021)
9.3.2 Latin America Multi-Infarct Dementia Market Size by Application (2022-2027)
9.3.3 Latin America Multi-Infarct Dementia Market Size by Application (2016-2027)
9.4 Latin America Multi-Infarct Dementia Market Size by Country
9.4.1 Latin America Multi-Infarct Dementia Market Size by Country (2016-2021)
9.4.2 Latin America Multi-Infarct Dementia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multi-Infarct Dementia Market Size (2016-2027)
10.2 Middle East & Africa Multi-Infarct Dementia Market Size by Type
10.2.1 Middle East & Africa Multi-Infarct Dementia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multi-Infarct Dementia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multi-Infarct Dementia Market Size by Type (2016-2027)
10.3 Middle East & Africa Multi-Infarct Dementia Market Size by Application
10.3.1 Middle East & Africa Multi-Infarct Dementia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multi-Infarct Dementia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multi-Infarct Dementia Market Size by Application (2016-2027)
10.4 Middle East & Africa Multi-Infarct Dementia Market Size by Country
10.4.1 Middle East & Africa Multi-Infarct Dementia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multi-Infarct Dementia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Forest Laboratories
11.1.1 Forest Laboratories Company Details
11.1.2 Forest Laboratories Business Overview
11.1.3 Forest Laboratories Multi-Infarct Dementia Introduction
11.1.4 Forest Laboratories Revenue in Multi-Infarct Dementia Business (2016-2021)
11.1.5 Forest Laboratories Recent Development
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Company Details
11.2.2 Janssen Pharmaceuticals Business Overview
11.2.3 Janssen Pharmaceuticals Multi-Infarct Dementia Introduction
11.2.4 Janssen Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021)
11.2.5 Janssen Pharmaceuticals Recent Development
11.3 Novartis Pharmaceutical
11.3.1 Novartis Pharmaceutical Company Details
11.3.2 Novartis Pharmaceutical Business Overview
11.3.3 Novartis Pharmaceutical Multi-Infarct Dementia Introduction
11.3.4 Novartis Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021)
11.3.5 Novartis Pharmaceutical Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Multi-Infarct Dementia Introduction
11.4.4 Pfizer Revenue in Multi-Infarct Dementia Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Multi-Infarct Dementia Introduction
11.5.4 Eisai Revenue in Multi-Infarct Dementia Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 Ortho-McNeil Pharmaceutical
11.6.1 Ortho-McNeil Pharmaceutical Company Details
11.6.2 Ortho-McNeil Pharmaceutical Business Overview
11.6.3 Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Introduction
11.6.4 Ortho-McNeil Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021)
11.6.5 Ortho-McNeil Pharmaceutical Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Multi-Infarct Dementia Introduction
11.7.4 Takeda Revenue in Multi-Infarct Dementia Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Jubilant Cadista Pharmaceuticals
11.8.1 Jubilant Cadista Pharmaceuticals Company Details
11.8.2 Jubilant Cadista Pharmaceuticals Business Overview
11.8.3 Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Introduction
11.8.4 Jubilant Cadista Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021)
11.8.5 Jubilant Cadista Pharmaceuticals Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Multi-Infarct Dementia Introduction
11.9.4 Takeda Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multi-Infarct Dementia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacological Treatment
Table 3. Key Players of Non Pharmacological Treatment
Table 4. Global Multi-Infarct Dementia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Multi-Infarct Dementia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Multi-Infarct Dementia Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Multi-Infarct Dementia Market Share by Regions (2016-2021)
Table 8. Global Multi-Infarct Dementia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Multi-Infarct Dementia Market Share by Regions (2022-2027)
Table 10. Multi-Infarct Dementia Market Trends
Table 11. Multi-Infarct Dementia Market Drivers
Table 12. Multi-Infarct Dementia Market Challenges
Table 13. Multi-Infarct Dementia Market Restraints
Table 14. Global Multi-Infarct Dementia Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Multi-Infarct Dementia Market Share by Players (2016-2021)
Table 16. Global Top Multi-Infarct Dementia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multi-Infarct Dementia as of 2020)
Table 17. Ranking of Global Top Multi-Infarct Dementia Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Multi-Infarct Dementia Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Multi-Infarct Dementia Product Solution and Service
Table 21. Date of Enter into Multi-Infarct Dementia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Multi-Infarct Dementia Revenue Market Share by Type (2016-2021)
Table 25. Global Multi-Infarct Dementia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Multi-Infarct Dementia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Multi-Infarct Dementia Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Multi-Infarct Dementia Revenue Market Share by Application (2016-2021)
Table 29. Global Multi-Infarct Dementia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Multi-Infarct Dementia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Multi-Infarct Dementia Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Multi-Infarct Dementia Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million)
Table 61. Forest Laboratories Company Details
Table 62. Forest Laboratories Business Overview
Table 63. Forest Laboratories Multi-Infarct Dementia Product
Table 64. Forest Laboratories Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 65. Forest Laboratories Recent Development
Table 66. Janssen Pharmaceuticals Company Details
Table 67. Janssen Pharmaceuticals Business Overview
Table 68. Janssen Pharmaceuticals Multi-Infarct Dementia Product
Table 69. Janssen Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 70. Janssen Pharmaceuticals Recent Development
Table 71. Novartis Pharmaceutical Company Details
Table 72. Novartis Pharmaceutical Business Overview
Table 73. Novartis Pharmaceutical Multi-Infarct Dementia Product
Table 74. Novartis Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 75. Novartis Pharmaceutical Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Multi-Infarct Dementia Product
Table 79. Pfizer Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Multi-Infarct Dementia Product
Table 84. Eisai Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. Ortho-McNeil Pharmaceutical Company Details
Table 87. Ortho-McNeil Pharmaceutical Business Overview
Table 88. Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Product
Table 89. Ortho-McNeil Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 90. Ortho-McNeil Pharmaceutical Recent Development
Table 91. Takeda Company Details
Table 92. Takeda Business Overview
Table 93. Takeda Multi-Infarct Dementia Product
Table 94. Takeda Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 95. Takeda Recent Development
Table 96. Jubilant Cadista Pharmaceuticals Company Details
Table 97. Jubilant Cadista Pharmaceuticals Business Overview
Table 98. Jubilant Cadista Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 99. Jubilant Cadista Pharmaceuticals Recent Development
Table 100. Takeda Pharmaceutical Company Details
Table 101. Takeda Pharmaceutical Business Overview
Table 102. Takeda Pharmaceutical Multi-Infarct Dementia Product
Table 103. Takeda Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million)
Table 104. Takeda Pharmaceutical Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multi-Infarct Dementia Market Share by Type: 2020 VS 2027
Figure 2. Pharmacological Treatment Features
Figure 3. Non Pharmacological Treatment Features
Figure 4. Global Multi-Infarct Dementia Market Share by Application: 2020 VS 2027
Figure 5. Academic Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Other Case Studies
Figure 8. Multi-Infarct Dementia Report Years Considered
Figure 9. Global Multi-Infarct Dementia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Multi-Infarct Dementia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Multi-Infarct Dementia Market Share by Regions: 2020 VS 2027
Figure 12. Global Multi-Infarct Dementia Market Share by Regions (2022-2027)
Figure 13. Global Multi-Infarct Dementia Market Share by Players in 2020
Figure 14. Global Top Multi-Infarct Dementia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multi-Infarct Dementia as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Multi-Infarct Dementia Revenue in 2020
Figure 16. Global Multi-Infarct Dementia Revenue Market Share by Type (2016-2021)
Figure 17. Global Multi-Infarct Dementia Revenue Market Share by Type (2022-2027)
Figure 18. North America Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Multi-Infarct Dementia Market Share by Type (2016-2027)
Figure 20. North America Multi-Infarct Dementia Market Share by Application (2016-2027)
Figure 21. North America Multi-Infarct Dementia Market Share by Country (2016-2027)
Figure 22. United States Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Multi-Infarct Dementia Market Share by Type (2016-2027)
Figure 26. Europe Multi-Infarct Dementia Market Share by Application (2016-2027)
Figure 27. Europe Multi-Infarct Dementia Market Share by Country (2016-2027)
Figure 28. Germany Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Multi-Infarct Dementia Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Multi-Infarct Dementia Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Multi-Infarct Dementia Market Share by Region (2016-2027)
Figure 38. China Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Multi-Infarct Dementia Market Share by Type (2016-2027)
Figure 46. Latin America Multi-Infarct Dementia Market Share by Application (2016-2027)
Figure 47. Latin America Multi-Infarct Dementia Market Share by Country (2016-2027)
Figure 48. Mexico Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Multi-Infarct Dementia Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Multi-Infarct Dementia Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Multi-Infarct Dementia Market Share by Country (2016-2027)
Figure 54. Turkey Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Forest Laboratories Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 58. Janssen Pharmaceuticals Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 59. Novartis Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 61. Eisai Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 62. Ortho-McNeil Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 64. Jubilant Cadista Pharmaceuticals Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の認知症・運動障害治療市場規模・現状・予測（2021年-2027年）

Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1758 2021年4月 91Pages
QYResearch社発行の本調査資料では、認知症・運動障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）、用途別市場規模（病院、クリニ...

世界の認知症治療薬市場 2021：企業別、地域別、種類・用途別

Global Dementia Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z04215 2021年4月 101Pages
当調査資料では、認知症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。認知症治療薬の種類別市場規模（MAO阻害剤、コリンエステラーゼ阻害剤、グルタメート阻害剤）、用途別市場規模（病院薬局、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロ...

世界のマルチサービスビジネスゲートウェイ（MSBG）市場規模・現状・予測（2021年-2027年）

Global Multi-Service Business Gateway (MSBG) Market Size, Status and Forecast 2021-2027
QYR2104Z3962 2021年4月 95Pages
QYResearch社発行の本調査資料では、マルチサービスビジネスゲートウェイ（MSBG）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一般、上質）、用途別市場規模（OEM、アフターマーケット）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のマルチアクセスレーザー微細加工市場規模・現状・予測（2021年-2027年）

Global Multi-Access Laser Micromachining Market Size, Status and Forecast 2021-2027
QYR2104Z3945 2021年4月 92Pages
QYResearch社発行の本調査資料では、マルチアクセスレーザー微細加工のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CO2レーザー微細加工、IRレーザー微細加工、グリーンレーザー微細加工、UVレーザー微細加工、その他）、用途別市場規模（自...

世界のマルチチャネル通信サービス市場規模・現状・予測（2021年-2027年）

Global Multi-Channel Communication Services Market Size, Status and Forecast 2021-2027
QYR2104Z3946 2021年4月 99Pages
QYResearch社発行の本調査資料では、マルチチャネル通信サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（有線チャネル、無線チャネル）、用途別市場規模（音声、メール、ソーシャルメディア、ビデオ会議、その他）、主要地域別市場規模（北米...

世界の立体型駐車場市場規模・現状・予測（2021年-2027年）

Global Multi-Storey Car Parks Market Size, Status and Forecast 2021-2027
QYR2104Z3964 2021年4月 92Pages
QYResearch社発行の本調査資料では、立体型駐車場のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自動ロボットシステム、照明）、用途別市場規模（商業地、住宅地、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界のインタラクティブマルチチャネル通信サービス市場規模・現状・予測（2021年-2027年）

Global Interactive Multi-Channel Communication Service Market Size, Status and Forecast 2021-2027
QYR2104Z3207 2021年4月 93Pages
QYResearch社発行の本調査資料では、インタラクティブマルチチャネル通信サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（専用チャネル、公共チャネル）、用途別市場規模（音声、メール、ソーシャルメディア、ビデオ会議、その他）、主要地域...

世界のマルチサービスビジネスゲートウェイ市場規模・現状・予測（2021年-2027年）

Global Multi-Service Business Gateways Market Size, Status and Forecast 2021-2027
QYR2104Z3963 2021年4月 95Pages
QYResearch社発行の本調査資料では、マルチサービスビジネスゲートウェイのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（通信セッション脅威、ネットワーク脅威、メディア脅威、アプリケーション脅威）、用途別市場規模（OEM、大企業、中小企業）...

世界の自動車用マルチホイールドライブ（AWD）システム市場規模・現状・予測（2021年-2027年）

Global Automotive Multi Wheel Drive (AWD) Systems Market Size, Status and Forecast 2021-2027
QYR2104Z0626 2021年4月 93Pages
QYResearch社発行の本調査資料では、自動車用マルチホイールドライブ（AWD）システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パートタイム、フルタイム、自動全輪駆動）、用途別市場規模（乗用車、商用車）、主要地域別市場規模（北米、ア...

世界の自動車用マルチホイールドライブ（AWD）システム市場規模・現状・予測（2021年-2027年）

世界の認知症・運動障害治療市場規模・現状・予測（2021年-2027年） Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…
世界の不眠症薬理学的治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Insomnia Pharmacological Treatment Market The global Insomnia Pharmacological Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
世界の認知症治療薬市場 2021：企業別、地域別、種類・用途別 The Dementia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
世界のマルチサービスビジネスゲートウェイ（MSBG）市場規模・現状・予測（2021年-2027年） A multi-service business gateway (MSBG) is a device that combines multiple network voice and data communications functions into a single device. Targeted at small and medium enterprises (SMEs), the MSBG integrates critical functions such as routing, VoIP, and security (virtual private networking, fi…
世界のマルチアクセスレーザー微細加工市場規模・現状・予測（2021年-2027年） Laser micromachining encompasses many processes including laser cutting, laser drilling, laser ablation, laser scribing, laser texturing as well as advanced laser machining processes. Multi-access Laser Micromachining provides maximum micromachining flexibility by supporting up to two or more laser …